Royalty Pharma Picks GC To Replace Retiring CLO
Pharmaceutical investment firm Royalty Pharma will soon have a new executive vice president and chief legal officer, as George Lloyd has decided to retire from that role effective Dec. 31, according...To view the full article, register now.
Already a subscriber? Click here to view full article